EGF and schizophrenia: Given the interactions between these systems, the EGF family and its signaling are augmented in the immune–inflammatory hypothesis of schizophrenia [29,30,31,32,33], potentially suggesting a substantial impact on the later risk of schizophrenia or other psychiatric diseases following the COVID-19 pandemic [34,35,36].